Eric K Nakakura
Overview
Explore the profile of Eric K Nakakura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
2279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wong P, Wisneski A, Tsai K, Chang T, Hirose K, Nakakura E, et al.
World J Surg Oncol
. 2024 Mar;
22(1):77.
PMID: 38468341
Background: Metastatic melanoma to the small bowel is an aggressive disease often accompanied by obstruction, abdominal pain, and gastrointestinal bleeding. With advancements in melanoma treatment, the role for metastasectomy continues...
12.
Chiorean E, Del Chiaro M, Tempero M, Malafa M, Benson A, Cardin D, et al.
J Natl Compr Canc Netw
. 2023 Jul;
21(7):753-782.
PMID: 37433437
Ampullary cancers refer to tumors originating from the ampulla of Vater (the ampulla, the intraduodenal portion of the bile duct, and the intraduodenal portion of the pancreatic duct), while periampullary...
13.
Kasai Y, Nakakura E, Yogo A, Nagai K, Masui T, Hatano E
Ann Surg Oncol
. 2023 Jul;
30(9):5457-5458.
PMID: 37394668
No abstract available.
14.
Wang S, Whitman J, Paciorek A, Le B, Nakakura E, Behr S, et al.
J Neuroendocrinol
. 2023 Apr;
35(4):e13260.
PMID: 37002881
Refined risk stratification for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has the potential to improve comparisons of study populations across clinical trials and facilitate drug development. Tumor growth rate (TGR) is a...
15.
16.
Kasai Y, Masui T, Nakakura E, Nakano K, Sato A, Uchida Y, et al.
Pancreatology
. 2021 Nov;
22(1):123-129.
PMID: 34736838
Background: /Objectives: Although the presence of lymph node metastasis (LNM) defines malignant potential, preoperative prediction of LNM has not been established for non-functional pancreatic neuroendocrine neoplasm (NF-PNEN). We sought to...
17.
18.
Chen K, Lawhn-Heath C, Behr S, Juarez R, Whitman J, Paciorek A, et al.
PLoS One
. 2021 Jun;
16(6):e0252574.
PMID: 34077464
Background: Neuroendocrine neoplasms (NENs) comprise a rare and heterogenous group of cancers, for which the role of radiation therapy continues to evolve. The purpose of this study is to analyze...
19.
Chan H, Zhang L, Choti M, Kulke M, Yao J, Nakakura E, et al.
Pancreas
. 2021 May;
50(4):506-512.
PMID: 33939661
Objective: Current National Comprehensive Cancer Network guidelines for gastroenteropancreatic neuroendocrine tumors (GEPNETs) recommend complete (R0) surgical resection of the primary tumor and metastases, if feasible. However, large multicenter studies of...
20.
Tempero M, Malafa M, Al-Hawary M, Behrman S, Benson A, Cardin D, et al.
J Natl Compr Canc Netw
. 2021 Apr;
19(4):439-457.
PMID: 33845462
Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis. The...